Prevalence and management of drug related problems at an intensive care unit

被引:0
|
作者
Lundereng, K. [1 ]
Sund, J. K. [2 ]
Sporsem, H. M. [3 ]
Pedersen, R. [4 ]
Molden, E. [5 ]
机构
[1] Levanger Hosp Pharm, Cent Norway Hosp Pharm Trust, Levanger, Norway
[2] Norwegian Univ Sci & Technol, Cent Norway Hosp Pharm Trust, Dept Lab Med Childrens & Womens Hlth, N-7034 Trondheim, Norway
[3] Oslo Hosp Pharm, Oslo, Norway
[4] Levanger Hosp, Helse Nord Trondelag Hosp Trust, Dept Emergency Med & Intens Care, Levanger, Norway
[5] Univ Oslo, Sch Pharm, Oslo, Norway
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:927 / 927
页数:1
相关论文
共 50 条
  • [41] PREVALENCE AND OUTCOMES OF HYPEROXIA IN THE INTENSIVE CARE UNIT
    Shaefi, Shahzad
    Mueller, Ariel
    -Goodspeed, Valerie Banner
    Shahul, Sajid
    Sarge, Todd
    Sevransky, Jonathan
    Talmor, Daniel
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [42] Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital
    Albayrak, Aslinur
    Basgut, Bilgen
    Bikmaz, Gulbin Aygencel
    Karahalil, Bensu
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [43] Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital
    Aslınur Albayrak
    Bilgen Başgut
    Gülbin Aygencel Bıkmaz
    Bensu Karahalil
    [J]. BMC Health Services Research, 22
  • [44] A prospective study on evaluation of clinical pharmacist's interventions regarding drug-related problems in intensive care unit
    Kocberber, E. Karatas
    Apikoglu-Rabus, S.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 345 - 345
  • [45] Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital
    Wang, Haitao
    Shi, Haitao
    Wang, Na
    Wang, Yan
    Zhang, Li
    Zhao, Yujie
    Xie, Jiao
    [J]. BMC PHARMACOLOGY & TOXICOLOGY, 2022, 23 (01):
  • [46] Prevalence of potential drug − drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital
    Haitao Wang
    Haitao Shi
    Na Wang
    Yan Wang
    Li Zhang
    Yujie Zhao
    Jiao Xie
    [J]. BMC Pharmacology and Toxicology, 23
  • [47] Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil
    Moreira Reis, Adriano Max
    De Bortoli Cassiani, Silvia Helena
    [J]. CLINICS, 2011, 66 (01) : 9 - 15
  • [49] ETHICAL AND FAMILY MANAGEMENT PROBLEMS IN THE INTENSIVE-CARE UNIT - AN ILLUSTRATIVE CASE
    BURDEN, JM
    FREEDMAN, B
    GELB, AW
    [J]. CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1987, 34 (03): : 274 - 279
  • [50] Immunotherapy & cytokine storm: intensive care management of immune related toxicities: from outpatient to intensive care unit
    Viardot, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 143 - 143